These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36481614)

  • 1. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
    Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R
    Trials; 2012 May; 13():74. PubMed ID: 22647439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal fentanyl for the management of acute pain in children.
    Murphy A; O'Sullivan R; Wakai A; Grant TS; Barrett MJ; Cronin J; McCoy SC; Hom J; Kandamany N
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD009942. PubMed ID: 25300594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
    Kang HA; Barner JC
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative review of the clinical use of intranasal fentanyl versus morphine in a paediatric emergency department.
    Borland ML; Clark LJ; Esson A
    Emerg Med Australas; 2008 Dec; 20(6):515-20. PubMed ID: 19125831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric emergency department triage-based pain guideline utilizing intranasal fentanyl: Effect of implementation.
    Schoolman-Anderson K; Lane RD; Schunk JE; Mecham N; Thomas R; Adelgais K
    Am J Emerg Med; 2018 Sep; 36(9):1603-1607. PubMed ID: 29371045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?
    Dhebaria T; Sivitz A; Tejani C
    Acad Emerg Med; 2021 Jun; 28(6):639-646. PubMed ID: 33025690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline.
    Kang HA; Wang B; Barner JC; Ataga KI; Mignacca RC; Chang A; Zhang Y
    JAMA Intern Med; 2024 May; 184(5):510-518. PubMed ID: 38466269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
    Borland M; Jacobs I; King B; O'Brien D
    Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expedited Delivery of Pain Medication for Long-Bone Fractures Using an Intranasal Fentanyl Clinical Pathway.
    Schacherer NM; Erikson Ramirez D; Frazier SB; Perkins AM
    Pediatr Emerg Care; 2015 Aug; 31(8):560-3. PubMed ID: 25875994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department.
    Paquin H; Trottier ED; Pastore Y; Robitaille N; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2020 Aug; 25(5):293-299. PubMed ID: 32765165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
    Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
    J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.